『A New Frontier in the Co-Management of Thyroid Eye Disease』のカバーアート

A New Frontier in the Co-Management of Thyroid Eye Disease

A New Frontier in the Co-Management of Thyroid Eye Disease

著者： Annenberg Center for Health Sciences
無料で聴く

このコンテンツについて

 Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, FACS, moderates this series of six, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatmentAnnenberg Center for Health Sciences 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Radiation, Surgery

    Radiation, Surgery
    2021/09/24
    • The role for external beam radiation and orbital decompression in treating patients with thyroid eye disease
    • Other surgical options for treating patients with thyroid eye disease
    続きを読む 一部表示
    13 分
  • Clinical Trials Experience

    Clinical Trials Experience
    2021/09/24
    • Clinical data supporting the approval of teprotumumab
    • How efficacy was assessed in the teprotumumab trials
    • Emerging therapies for patients with thyroid eye disease
    続きを読む 一部表示
    16 分
  • Treatment

    Treatment
    2021/09/24
    • The role of intervention in patient management
    • Therapy selection for patients with thyroid eye disease
    • Evaluating treatment responses
    続きを読む 一部表示
    15 分

A New Frontier in the Co-Management of Thyroid Eye Diseaseに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。